معرفی
Anna Mihailova is an Assistant Professor in the Department of Internal Diseases at Rīga Stradiņš University, Faculty of Medicine. Her work contributes to the UN Sustainable Development Goal 3 (Good Health and Well-being), particularly through research in clinical medicine and rheumatology. She is actively involved in studying autoimmune and inflammatory rheumatic diseases, with a focus on systemic sclerosis, osteoarthritis, and synovial fluid biomarkers.
Her research interests span rheumatology, autoimmune diseases, inflammatory arthritis, systemic sclerosis, osteoarthritis, and neurodegenerative disorders. She investigates the role of biomarkers such as interleukin-6 in synovial fluid for differentiating degenerative from inflammatory joint diseases, and explores links between hypouricemia and neurodegeneration. Her work combines clinical observation with translational research to improve diagnostic and therapeutic strategies.
The trend in her recent publications (2020–2024) reflects a strong focus on systemic sclerosis epidemiology in Latvia, gender-specific disease patterns, pain management in the elderly, and biomarker validation. These studies are primarily clinical and observational, often involving multicenter collaborations and cohort analyses. Her work appears in journals related to internal medicine, rare diseases, and translational neuroprotection.
Scientific Activities and Recognition:
- Active contributor to peer review (e.g., RSU Research Week 2021)
- Poster presenter on hereditary hemochromatosis-related arthritis
- Media contributor on joint pain topics (e.g., 'Muguras sāpes' – Back Pain)
- ORCID: 0000-0003-2541-4296
Advising and Grants: While no formal list of students or grants is provided, her involvement in doctoral theses and multicenter studies suggests mentorship and collaborative research roles. She has co-authored a doctoral thesis and contributed to preprints and specialist articles, indicating engagement in academic training and knowledge dissemination.
Laboratories and Teams: She collaborates within a Latvian rheumatology research network, particularly with researchers from Rīga Stradiņš University and regional hospitals. Her work on systemic sclerosis involves a multicenter team analyzing demographic, immunological, and clinical data from Latvian patients, suggesting integration into a national research consortium focused on rare autoimmune diseases.
